Mariette van der Velden is a Co-Founder and the Managing Partner at Curie Capital. She serves as Supervisory Board Member at TargED Biotherapeutics and at Cleara Biotech. She has an extensive background in the field of Life Sciences as she has 26 years of experience working for and with international companies developing and selling new medical technologies and medicines. During these years she gained in-depth experience and expertise in the field through a broad range of companies and products. From 2013 until 2018 she was Senior Investment Manager Life Sciences & Health at BOM Brabant Ventures. Here she was responsible for the management of up to 13 portfolio companies where she represented BOM as a shareholder and, to a number of these companies, as Board Member. Before working as a Life Science investor, she had 17 years of all-around management and business development experience in biotech such as Genzyme and Uniqure. This includes being highly involved in many innovative start-up ventures and the international launch of innovative products. For the success of Curie Capital, she uses her broad knowledge and experience in the Life Sciences field to select high potential start-ups for seed and follow-on investment.